Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
作者信息
Oh Joo Hyun, Sinn Dong Hyun
机构信息
Department of Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2023 Apr;29(2):367-370. doi: 10.3350/cmh.2023.0054. Epub 2023 Mar 20.
Abstract
摘要
相似文献
1
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?肝活检对于识别慢性乙型肝炎免疫耐受期是否必不可少？
Clin Mol Hepatol. 2023 Apr;29(2):367-370. doi: 10.3350/cmh.2023.0054. Epub 2023 Mar 20.
2
Letter regarding "Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?".关于“肝活检对于确定慢性乙型肝炎免疫耐受期是否必不可少？”的信函
Clin Mol Hepatol. 2023 Jul;29(3):812. doi: 10.3350/cmh.2023.0132. Epub 2023 May 8.
3
Correspondence on Letter regarding "Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?".关于“肝活检对于识别慢性乙型肝炎免疫耐受期是否必不可少？”的信件往来
Clin Mol Hepatol. 2023 Jul;29(3):820. doi: 10.3350/cmh.2023.0135. Epub 2023 May 19.
4
Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase.中国免疫耐受期慢性乙型肝炎患者的自然史和疾病进展
Hepatology. 2007 Aug;46(2):395-401. doi: 10.1002/hep.21724.
5
Liver biopsy findings in chronic hepatitis B.慢性乙型肝炎的肝活检结果。
Hepatology. 2009 May;49(5 Suppl):S61-71. doi: 10.1002/hep.22930.
6
Liver biopsy assessment in chronic hepatitis.慢性肝炎的肝活检评估
Arch Med Res. 2007 Aug;38(6):634-43. doi: 10.1016/j.arcmed.2006.08.005.
7
Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase.慢性乙型肝炎血清学免疫耐受期的长期预后和组织学评估的必要性。
Clin Mol Hepatol. 2023 Apr;29(2):482-495. doi: 10.3350/cmh.2022.0322. Epub 2023 Jan 5.
8
Unresolved issues of immune tolerance in chronic hepatitis B.慢性乙型肝炎免疫耐受未解决的问题。
J Gastroenterol. 2020 Apr;55(4):383-389. doi: 10.1007/s00535-020-01665-z. Epub 2020 Feb 3.
9
The imitator of immune-tolerant chronic hepatitis B: A killer in disguise.免疫耐受型慢性乙型肝炎的模仿者：一个伪装的杀手。
Clin Mol Hepatol. 2023 Apr;29(2):363-366. doi: 10.3350/cmh.2023.0079. Epub 2023 Mar 9.
10
Is liver biopsy still needed in children with chronic viral hepatitis?慢性病毒性肝炎患儿仍需要进行肝活检吗？
World J Gastroenterol. 2015 Nov 14;21(42):12141-9. doi: 10.3748/wjg.v21.i42.12141.
引用本文的文献
1
Vibration-controlled transient elastography for significant fibrosis in treatment-naïve chronic hepatitis B patients: A systematic review and meta-analysis.振动控制瞬时弹性成像在未经治疗的慢性乙型肝炎患者中的显著纤维化评估：系统评价和荟萃分析。
Clin Mol Hepatol. 2024 Sep;30(Suppl):S106-S116. doi: 10.3350/cmh.2024.0371. Epub 2024 Jul 23.
2
The Relationship between Mean Platelet Volume and Neutrophil-Lymphocyte Ratio and Liver Fibrosis in Patients with Chronic Hepatitis B.血小板平均体积与中性粒细胞-淋巴细胞比值与慢性乙型肝炎患者肝纤维化的关系。
Medicina (Kaunas). 2023 Jul 12;59(7):1287. doi: 10.3390/medicina59071287.
3
Letter regarding "Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?".关于“肝活检对于确定慢性乙型肝炎免疫耐受期是否必不可少？”的信函
Clin Mol Hepatol. 2023 Jul;29(3):812. doi: 10.3350/cmh.2023.0132. Epub 2023 May 8.
本文引用的文献
1
The role of different viral biomarkers on the management of chronic hepatitis B.不同病毒标志物在慢性乙型肝炎管理中的作用。
Clin Mol Hepatol. 2023 Apr;29(2):263-276. doi: 10.3350/cmh.2022.0448. Epub 2023 Jan 19.
2
Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase.慢性乙型肝炎血清学免疫耐受期的长期预后和组织学评估的必要性。
Clin Mol Hepatol. 2023 Apr;29(2):482-495. doi: 10.3350/cmh.2022.0322. Epub 2023 Jan 5.
3
[Definition and Management of the Immune Tolerance Phase in Chronic Hepatitis B].[慢性乙型肝炎免疫耐受期的定义与管理]
Korean J Gastroenterol. 2022 Apr 25;79(4):156-160. doi: 10.4166/kjg.2022.049.
4
KASL clinical practice guidelines for management of chronic hepatitis B.《慢性乙型肝炎管理的KASL临床实践指南》
Clin Mol Hepatol. 2022 Apr;28(2):276-331. doi: 10.3350/cmh.2022.0084. Epub 2022 Apr 1.
5
Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients.乙肝核心相关抗原对预测乙肝e抗原阳性患者的阶段和预后有用。
J Clin Med. 2022 Mar 21;11(6):1729. doi: 10.3390/jcm11061729.
6
Cytokines and Chemokines in HBV Infection.乙型肝炎病毒感染中的细胞因子和趋化因子
Front Mol Biosci. 2021 Dec 2;8:805625. doi: 10.3389/fmolb.2021.805625. eCollection 2021.
7
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B.对于慢性乙型肝炎患者，生物标志物定义的免疫耐受期发生肝细胞癌的风险可忽略不计。
Clin Mol Hepatol. 2021 Apr;27(2):295-304. doi: 10.3350/cmh.2020.0216. Epub 2020 Dec 3.
8
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase.在免疫耐受期的慢性乙型肝炎患者中，肝细胞癌发展的风险极低。
Aliment Pharmacol Ther. 2020 Jul;52(1):196-204. doi: 10.1111/apt.15741. Epub 2020 May 26.
9
KASL clinical practice guidelines for management of chronic hepatitis B.《慢性乙型肝炎管理的KASL临床实践指南》
Clin Mol Hepatol. 2019 Jun;25(2):93-159. doi: 10.3350/cmh.2019.1002. Epub 2019 Jun 12.
10
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.慢性乙型肝炎的预防、诊断和治疗最新进展：美国肝病研究学会2018年乙型肝炎指南
Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800.
Zotero 插件